The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Online Registry for Mutations in Hereditary Amyloidosis Including Nomenclature Recommendations
Open accessAbstract
Hereditary systemic amyloidosis comprises a group of rare monogenic diseases inherited in an autosomal dominant fashion. It is associated with mutations in genes encoding eight different proteins, including transthyretin, apolipoprotein AI, apolipoprotein AII, lysozyme, fibrinogen A α-chain, cystatin C, gelsolin and beta-2-microglobulin. With support from the EU FP6 EURAMY project we have designed an online registry of genes and mutations in hereditary amyloidosis including their associated clinical phenotypes, with a view to having a single free online portal for the collection and distribution of this information. Users can search the registry by either mutation, phenotype or authors who have published or submitted mutations. It provides a submission form for reporting newly identified mutations. We also wanted to introduce nomenclature which complies with recommendations set out by Human Genome Variation Society and HUGO Gene Nomenclature Committee for description of new and known genetic variants. We hope this registry would be a useful and convenient tool for the medical and scientific community.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human lysozyme gene mutations cause hereditary systemic amyloidosis
Pepys, M. B., Hawkins, P. N., Booth, D. R., Vigushin, D. M., Tennent, G. A., Soutar, A. K., Totty, N., Nguyen, O., Blake, C. C. F., Terry, C. J., et al. (1993) · Nature · doi:10.1038/362553a0 · Cited by 657
Self-citationPepys, M. B. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131243 · Cited by 559
Variant-Sequence Transthyretin (Isoleucine 122) in Late-Onset Cardiac Amyloidosis in Black Americans
Jacobson, D. R., Pastore, R. D., Yaghoubian, R., Kane, I., Gallo, G., Buck, F. S., & Buxbaum, J. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702133360703 · Cited by 554
Tabulation of human transthyretin (TTR) variants, 2003
Connors, L. H., Lim, A., Prokaeva, T., Roskens, V. A., & Costello, C. E. (2003) · Amyloid · doi:10.3109/13506120308998998 · Cited by 505
Saraiva, M. J., Birken, S., Costa, P. P., & Goodman, D. S. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111390 · Cited by 434
Ghiso, J., Jensson, O., & Frangione, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2974 · Cited by 332
Sipe, J. D., Benson, M. D., Buxbaum, J. N., Ikeda, S.-I., Merlini, G., Saraiva, M. J. M., & Westermark, P. (2012) · Amyloid · doi:10.3109/13506129.2012.734345 · Cited by 311
Self-citationVariant apolipoprotein AI as a major constituent of a human hereditary amyloid
Nichols, W. C., Dwulet, F. E., Liepnieks, J., & Benson, M. D. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80909-4 · Cited by 233
Hereditary renal amyloidosis associated with a mutant fibrinogen α–chain
Benson, M. D., Liepnieks, J., Uemichi, T., Wheeler, G., & Correa, R. (1993) · Nature Genetics · doi:10.1038/ng0393-252 · Cited by 219
Benson, M. D., & Uemichi, T. (1996) · Amyloid · doi:10.3109/13506129609014354 · Cited by 187
Cited by
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Gillmore, J. D., Maurer, M. S., Falk, R. H., Merlini, G., Damy, T., Dispenzieri, A., Wechalekar, A. D., Berk, J. L., Quarta, C. C., Grogan, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021612 · Cited by 2,081
Self-citationA new staging system for cardiac transthyretin amyloidosis
Gillmore, J. D., Damy, T., Fontana, M., Hutchinson, M., Lachmann, H. J., Martinez-Naharro, A., Quarta, C. C., Rezk, T., Whelan, C. J., Gonzalez-Lopez, E., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx589 · Cited by 776
Self-citationBenson, M. D., Buxbaum, J. N., Eisenberg, D. S., Merlini, G., Saraiva, M. J. M., Sekijima, Y., Sipe, J. D., & Westermark, P. (2018) · Amyloid · doi:10.1080/13506129.2018.1549825 · Cited by 566
Self-citationNatural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis
Lane, T., Fontana, M., Martinez-Naharro, A., Quarta, C. C., Whelan, C. J., Petrie, A., Rowczenio, D. M., Gilbertson, J. A., Hutt, D. F., Rezk, T., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038169 · Cited by 535
Self-citationSolomon, S. D., Adams, D., Kristen, A., Grogan, M., González-Duarte, A., Maurer, M. S., Merlini, G., Damy, T., Slama, M. S., Brannagan, T. H., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.035831 · Cited by 462
Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease
Adams, D., Koike, H., Slama, M., & Coelho, T. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0210-4 · Cited by 448
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
Adams, D., Ando, Y., Beirão, J. M., Coelho, T., Gertz, M. A., Gillmore, J. D., Hawkins, P. N., Lousada, I., Suhr, O. B., & Merlini, G. (2021) · Journal of Neurology · doi:10.1007/s00415-019-09688-0 · Cited by 314
Self-citation“Red‐flag” symptom clusters in transthyretin familial amyloid polyneuropathy
Conceição, I., González‐Duarte, A., Obici, L., Schmidt, H. H. ‐., Simoneau, D., Ong, M., & Amass, L. (2016) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12153 · Cited by 299
Self-citationPatisiran, an RNAi Therapeutic for the Treatment of Hereditary Transthyretin-Mediated Amyloidosis
Kristen, A. V., Ajroud-Driss, S., Conceição, I., Gorevic, P., Kyriakides, T., & Obici, L. (2019) · Neurodegenerative Disease Management · doi:10.2217/nmt-2018-0033 · Cited by 268
Self-citationThe Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans
Quarta, C. C., Buxbaum, J. N., Shah, A. M., Falk, R. H., Claggett, B., Kitzman, D. W., Mosley, T. H., Butler, K. R., Boerwinkle, E., & Solomon, S. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1404852 · Cited by 263
Gertz, M. A., Scheinberg, M., Waddington-Cruz, M., Heitner, S. B., Karam, C., Drachman, B., Khella, S., Whelan, C., & Obici, L. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1635008 · Cited by 38
Self-citation
Metadata
- Authors
- Rowczenio, D. M., Noor, I., Gillmore, J. D., Lachmann, H. J., Whelan, C., Hawkins, P. N., Obici, L., Westermark, P., Grateau, G., & Wechalekar, A. D.
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 2014-08-04
- Volume
- 35
- Issue
- 9
- Pages
- E2403-E2412
- ISSN
- 1059-7794 (ISSN-L)
- OpenAlex
- W1986782676
- Cited by
- 308
- References
- 24
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.